NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

BACKGROUND: The signal transduction pathways of epidermal growth factor receptor and Ras are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that inhibition of both pathways would improve the survival time of patients with recurrent GBM. METHODS: Patients with recurren...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Peereboom, David M., Ahluwalia, Manmeet S., Ye, Xiaobu, Supko, Jeffrey G., Hilderbrand, Sarah L., Phuphanich, Surasak, Nabors, L. Burt, Rosenfeld, Myrna R., Mikkelsen, Tom, Grossman, Stuart A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2013
Schlagworte:
Clinical Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607264/
https://ncbi.nlm.nih.gov/pubmed/23328813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos322
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge